KIO-104

· Kiora Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KIO-104, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema [Phase 2]